Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nuclear war: the granzyme A-bomb.

Judy Lieberman1, Zusen Fan

  • 1Center for Blood Research and Department of Pediatrics, Harvard Medical School, 800 Huntington Avenue, Boston, MA 02115, USA. liberman@cbr.med.harvard.edu

Current Opinion in Immunology
|September 23, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of cross-stage, cross-species malaria CD8<sup>+</sup> T cell antigens.

Nature·2026
Same author

Administration of neuritin as a novel therapeutic strategy for autoimmune and inflammatory diseases.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

A cell-death protein has an unexpected role in intestinal repair.

Nature·2026
Same author

Small nucleolar RNA Snora61 drives self-renewal of intestinal stem cells via initiation of Lgr5 transcription.

Nature communications·2026
Same author

Pyroptosis: Turning Up the Heat on Cancer.

Annual review of immunology·2026
Same author

SNORA49 negatively regulates self-renewal of liver cancer stem cells and hepatocarcinogenesis via suppressing SOX9 transcription.

Nature communications·2026
Same journal

The food additive microbial transglutaminase is a potential new environmental inducer of autoimmune diseases.

Current opinion in immunology·2026
Same journal

Mapping the synovial immune ecosystem in rheumatoid arthritis: cellular cartography and pathotype-guided immune restoration.

Current opinion in immunology·2026
Same journal

Noncanonical ion channel signaling in neurovascular barrier regulation and immune cell trafficking.

Current opinion in immunology·2026
Same journal

A blind spot of human T cell immunology: epitope specificity in secondary lymphoid organs.

Current opinion in immunology·2026
Same journal

Germinal center responses at barrier organ sites.

Current opinion in immunology·2026
Same journal

Ocular sarcoidosis: from clinical signs to targeted interventions.

Current opinion in immunology·2026
See all related articles

Granzyme A induces cell death independently of caspases by damaging DNA and disrupting cell membranes. This serine protease targets key proteins in the nucleus and endoplasmic reticulum, offering a new pathway for eliminating resistant cells.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Granzyme A is a serine protease found in cytotoxic granules of immune cells.
  • It induces caspase-independent cell death through unknown mechanisms.
  • Granzyme A damages DNA and disrupts cell membrane integrity.

Purpose of the Study:

  • To elucidate the molecular mechanisms of Granzyme A-induced cell death.
  • To identify the substrates and pathways targeted by Granzyme A.
  • To understand the role of Granzyme A in eliminating resistant cells.

Main Methods:

  • Analysis of Granzyme A substrates.
  • Investigation of DNA damage and cell membrane integrity.
  • Study of mitochondrial transmembrane potential changes.

Related Experiment Videos

  • Characterization of the SET complex and its components.

    • Main Results:

    • Granzyme A targets lamins and histones, leading to nuclear envelope destruction and DNA degradation.
    • It disrupts the SET complex, releasing the DNase NM23-H1 and inhibiting DNA repair via Ape1 cleavage.
    • Granzyme A induces rapid loss of cell membrane integrity and mitochondrial potential.

    Conclusions:

    • Granzyme A initiates a novel cell death pathway parallel to apoptosis.
    • This pathway is crucial for eliminating target cells resistant to caspase-mediated apoptosis, such as those overexpressing bcl-2.
    • Granzyme A's action on the SET complex and DNA repair machinery highlights its potent cytotoxic function.